StockTipsArenaBeta

BUY Emcure Pharmaceuticals Limited — Ansh Jogendra Bhilwar

BUYEmcure Pharmaceuticals Limited
Emcure Pharmaceuticals share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: Intraday7 Sept 2026, 7:59 am ISTvia Zee Business (Live)

Entry₹1,934.8Inferred
Target₹1,985
Total upside +2.59% (call closed)
Stop loss₹1,898-1.90% risk
At expiry₹1,928.67 Sept 2026, 3:20 pm
Expired-0.32%
Follow Ansh Jogendra Bhilwar for new calls(20% target hit, 56 closed calls)Get alertsWatch EMCURE for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 7 Sept 2026
2 supporting2 neutral0 opposing
Supports the BUY call (2)

Emcure Pharma: Here's Why ICICI Direct Calls It A High-Conviction 'Buy'

NewsNdtv-Profit·7 Sept · today

(opens in new tab)

Broker’s call: Emcure Pharma (Buy)

NewsHbl·4 Sept · 2d ago

(opens in new tab)
Neutral / worth noting (2)

Market Trading Guide: Emcure Pharma among 2 stock recommendations for Monday

NewsEt-Markets·6 Sept · today

(opens in new tab)

Coal India, Emcure Pharma, Finolex Cables, GIC, Gulf Oil Lubricants Dividends: Last Day To Buy Shares To Qualify

NewsNdtv-Profit·3 Sept · 4d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Emcure Pharmaceuticals

All analyst calls on Emcure Pharmaceuticals

More from Ansh Jogendra Bhilwar

Every call and its outcome